Anika Reports Second Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. DRS
4. GS
5. BAC
6. ORCL
7. AVAV
8. ACI
9. UNH
10. JPM

Go back to Anika Reports Second Quarter 2024 Financial Results

Anika Therapeutics (ANIK) Tops Q2 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance

August 8, 2024 4:27 PM EDT

Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.17, $0.10 better than the analyst estimate of $0.07. Revenue for the quarter came in at $41.9 million versus the consensus estimate of $40.77 million.

GUIDANCE:

Anika Therapeutics sees FY2024 revenue of $168-173 million, versus the consensus... More